Unexplained weight loss (UWL) can often be a diagnostic dilemma in clinical practice. This article provides a comprehensive approach to evaluating such cases.
UWL, defined as a loss of more than 5% body weight over 6-12 months without a known cause, is often an indicator of underlying severe disease. It has been associated with increased morbidity and mortality, emphasizing the need for a thorough evaluation.
History taking and physical examination form the cornerstone of the diagnostic approach. Key areas to explore include dietary intake, physical activity levels, gastrointestinal symptoms, psychological factors, and medication use. A detailed review of systems can help identify potential organ systems involved.
Initial investigations should include a complete blood count, metabolic panel, thyroid function tests, and inflammatory markers. In the absence of specific symptoms, further testing should be guided by the patient's age, sex, and risk factors. Imaging studies may be considered based on clinical suspicion.
Management of UWL is directed at treating the underlying cause. In cases where no cause is identified, supportive measures including nutritional support and symptom management should be provided. Regular follow-up is essential to monitor for the emergence of new symptoms or signs.
Unexplained weight loss is a complex clinical problem requiring a systematic and comprehensive approach. A thorough history, physical examination, and judicious use of investigations are key to identifying the underlying cause. While the diagnostic process can be challenging, it is crucial to ensure appropriate management and improve patient outcomes.
1.
Regular physical activity before cancer diagnosis may lower progression and death risks
2.
Medication Self-Injection Embraced by Breast Cancer Patients
3.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
4.
FDA Advisors Split on Regimens for Breast, Prostate Cancers
5.
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs
1.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
2.
Clinical Pathways in Hematology in Clinical Decision-Making
3.
Immune Surveillance Screening for Early Cancer Risk Detection
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
Signs and Symptoms of Leukemia
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation